Skip to content
العربية

Science · Ingredient

Permethrin

Synthetic pyrethroid; neurotoxic pediculicide and scabicide

OtherHair & Scalp

Ingredient profiles describe what an ingredient is and why it is used in formulations. They are not efficacy claims.

What it is

A synthetic version of the natural insect-repelling compounds found in chrysanthemum flowers.

What it does

A precise strike on lice and scabies mites: it acts on their nerves so they can no longer move or feed, while human skin breaks it down quickly. It is one of the most widely used treatments for head lice and the reference treatment for scabies.

Evidence

Type I pyrethroid that binds arthropod voltage-gated sodium channels and delays their inactivation, producing repetitive firing, paralysis and death of lice and Sarcoptes scabiei. Human exposure is limited: under 2% of a topical dose is absorbed and it is rapidly hydrolysed by esterases. Scabies: in a Cochrane review of 15 RCTs (1896 participants), permethrin 5% gave clearance comparable to or better than oral ivermectin (Rosumeck 2018); a 2026 cluster-randomised trial in 1075 participants found 5% permethrin cream, applied head to toe on days 0 and 10, superior to oral ivermectin for household cure (Boralevi 2026). European guidance recommends application to the whole body, left for 8 to 12 hours and repeated after 7 to 14 days, with simultaneous treatment of contacts (Salavastru 2017). Head lice: permethrin 1% creme rinse has been a first-line pediculicide (AAP, Nolt 2022), but knockdown resistance mutations of the sodium channel are now widespread, reducing efficacy in many regions (Durand 2012). Not reliably ovicidal: a second application 7 to 10 days later is recommended.

References 6
  1. Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018;4(4):CD012994. doi:10.1002/14651858.CD012994. PMID 29608022
  2. Boralevi F, Simon G, Bernigaud C, et al. Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial. BMJ. 2026;392:e086277. doi:10.1136/bmj-2025-086277. PMID 41494769
  3. Salavastru CM, Chosidow O, Boffa MJ, et al. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017;31(8):1248-1253. doi:10.1111/jdv.14351. PMID 28639722
  4. Nolt D, Moore S, Yan AC, Melnick L. Head Lice. Pediatrics. 2022;150(4):e2022059282. doi:10.1542/peds.2022-059282. PMID 36156158
  5. Durand R, Bouvresse S, Berdjane Z, et al. Insecticide resistance in head lice: clinical, parasitological and genetic aspects. Clin Microbiol Infect. 2012;18(4):338-44. doi:10.1111/j.1469-0691.2012.03806.x. PMID 22429458
  6. Mytton OT, McGready R, Lee SJ, et al. Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG. 2007;114(5):582-7. doi:10.1111/j.1471-0528.2007.01290.x. PMID 17439567

Riviera products

Products that list this ingredient

Solutions

Related concerns